World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 4 March 2019
Main ID:  ISRCTN12967309
Date of registration: 25/08/2015
Prospective Registration: No
Primary sponsor: University of Medicine and Pharmacy Cluj-Napoca
Public title: Is quadriceps tendon a better choice than hamstring tendons for repairing anterior cruciate ligament lesion?
Scientific title: Anterior cruciate ligament reconstruction with free quadriceps versus quadrupled hamstring autografts
Date of first enrolment: 15/11/2013
Target sample size: 60
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN12967309
Study type:  Interventional
Study design:  Prospective longitudinal randomized parallel trial. (Treatment)  
Phase:  Not Applicable
Countries of recruitment
Romania
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Cristian    Buescu
Address:  40 Campului st, ap 87 400651 Cluj-Napoca Romania
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Aged between 16-50 years
2. Schedules for ACL repair.

Exclusion criteria:
1. Lesions older than 2 years, associated meniscus or other ligament lesion that required surgical management
2. Previous surgeries on the same knee.
3. Patients with chronic pain or hepatic impairment
4. Alcoholics or drug abusers.


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Anterior cruciate ligament chronic injury
Musculoskeletal Diseases
Anterior cruciate ligament chronic injury
Intervention(s)

We performed arthroscopic anatomic single-bundle anterior cruciate ligament reconstruction using either free quadriceps tendon autograft or quadrupled hamstring autograft (semitendinosus and gracilis tendons) .
A multimodal analgesic postoperative regimen was started 1 hour after surgery and consisted of acetaminophen (Paracetamol, Terapia-Ranbaxy, Cluj-Napoca, Romania) 500 mg per os (po) and ketorolac tromethamina (Ketorol, Dr. Reddy's Lab. (UK) LTD.) 15mg intravenous (iv) every 8 hours, for the first 49 postoperative hours. Rescue analgesia was provided with tramadol (AliudĀ® Pharma GmbH & Co. KG, Gottlieb-Daimler-Str. 19, D-89150 Laichingen, Germany) 30 mg iv bolus when patients declared pain scores of 30 or more on the Visual Analog Scale (VAS).
Primary Outcome(s)

1. Postoperative pain intensity was evaluated using the Visual Analog Scale, ranging from 0 to 100, with 0 to 30 considered mild pain, 30 to 70 moderate pain and over 70, severe pain.
2. Time to the first rescue analgesic requirement, the number of doses of tramadol and the pain score were recorded. The postoperative period was split three-way (first 12 hours post-op, 12-24 hours post-op, 24-48 hours post-op).
Secondary Outcome(s)
Follow-ups made at 6 weeks, 3 and 6 months after surgery with clinical assessment and Tegner and Lysholm self-evaluation questionnaires.
Secondary ID(s)
2015-003367-11
298
Source(s) of Monetary Support
University of Medicine and Pharmacy Cluj-Napoca, Clinical Emergency County Hospital of Cluj
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Iuliu Hatieganu University of Medicine and Pharmacy Ethics Committee, 29/07/2014, ref: 298/28.07.2014
Results
Results available: Yes
Date Posted:
Date Completed: 20/05/2015
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history